Nundina › Discover calendars › FDA Advisory Committee Meetings calendar › FDA advisory committee: Dermatologic and Ophthalmic Drugs Advisory Committee - New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%FDA advisory committee: Dermatologic and Ophthalmic Drugs Advisory Committee - New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%30 October 2026 at 12:30 UTCPublic meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee, announced by the FDA in the Federal Register on 2026-09-25. Topic: New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%. Times are as stated in the notice (Eastern Time).FDA Advisory Committee Meetings calendarMore from this calendar

19 November 2026 at 14:00 UTC - FDA advisory committee: Microbiology Devices Panel of the Medical Devices Advisory Committee - Pathogen-Agnostic Sequencing